MedTech Dealmakers October 2015

Medtech Dealmakers is a first-of-its-kind partnering supplement to Nature Biotechnology, Nature Medicine and Nature Reviews Drug Discovery exploring the dealmaking trends of the growing medical technology industry. With reviews of the partnering landscape and a showcase of innovative companies seeking partners, this is a new must-read publication for medical technology professionals.

Like Comment

Read the first edition of MedTech Dealmakers

Read about the companies working in the medical technology industry and looking for partnerships from our first medtech edition -

Lohmann & Rauscher


The University of Tokyo

Histide AG

NuGEN Technologies Inc




Pacific Edge

Read the in-depth partnering features from our first medtech edition -

Key drivers in the medical technology deal landscape

Genomics technologies march into new markets

Precision medicine’s invigorating effect on cancer medical technology

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.